Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
4(31%)
Results Posted
20%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
9
69%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (10.0%)
N/A9 (90.0%)

Trials by Status

active_not_recruiting18%
terminated18%
unknown323%
completed538%
recruiting323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
PROCEDURE
Total Trials
13